Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Scheggi, Simonaa; 1 | Rossi, Francescab; 1 | Corsi, Sarab | Fanni, Silviab | Tronci, Elisabettab | Ludovica, Congiub | Vargiu, Rominab | Gambarana, Carlaa | Muñoz, Anac | Stancampiano, Robertob | Björklund, Andersd | Carta, Manolob; *
Affiliations: [a] Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy | [b] Department of Biomedical Sciences, Cagliari University, Cagliari, Italy | [c] Department of Morphological Sciences, CIMUS, University of Santiago de Compostela, Santiago de Compostela, Spain | [d] Department of Experimental Medical Science, Wallenberg Neuroscience Center, Division of Neurobiology, Lund University, Lund, Sweden
Correspondence: [*] Corresponding author. Manolo Carta, Department of Biomedical Sciences, Section of Physiology, University of Cagliari, Cittadella Universitaria, SS554, km 4.5, 09042 Monserrato, Italy. Tel.: +39 0706756697; Fax: +39 0706754191; E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background:We recently showed that striatal overexpression of brain derived neurotrophic factor (BDNF) by adeno-associated viral (AAV) vector exacerbated L-DOPA-induced dyskinesia (LID) in 6-OHDA-lesioned rats. An extensive sprouting of striatal serotonergic terminals accompanied this effect, accounting for the increased susceptibility to LID. Objective:We set to investigate whether the BDNF effect was restricted to LID, or extended to dyskinesia induced by direct D1 receptor agonists. Methods:Unilaterally 6-OHDA-lesioned rats received a striatal injection of an AAV vector to induce BDNF or GFP overexpression. Eight weeks later, animals received daily treatments with a low dose of SKF82958 (0.02 mg/kg s.c.) and development of dyskinesia was evaluated. At the end of the experiment, D1 and D3 receptors expression levels and D1 receptor-dependent signaling pathways were measured in the striatum. Results:BDNF overexpression induced significant worsening of dyskinesia induced by SKF82958 compared to the GFP group and increased the expression of D3 receptor at striatal level, even in absence of pharmacological treatment; by contrast, D1 receptor levels were not affected. In BDNF-overexpressing striata, SKF82958 administration resulted in increased levels of D1–D3 receptors co-immunoprecipitation and increased phosphorylation levels of Thr34 DARPP-32 and ERK1/2. Conclusion:Here we provide evidence for a functional link between BDNF, D3 receptors and D1–D3 receptor close interaction in the augmented susceptibility to dyskinesia in 6-OHDA-lesioned rats. We suggest that D1–D3 receptors interaction may be instrumental in driving the molecular alterations underlying the appearance of dyskinesia; its disruption may be a therapeutic strategy for treating dyskinesia in PD patients.
Keywords: 6-OHDA, BDNF, dyskinesia, D3 receptors, Parkinson’s disease
DOI: 10.3233/JPD-202061
Journal: Journal of Parkinson's Disease, vol. 10, no. 4, pp. 1503-1514, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]